Skip to main content

Find Clinical Trials

Home
Conditions
Neoplasms, Plasma Cell

Clinical trial condition

Neoplasms, Plasma Cell

Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.

512 public trials 52 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms, Plasma Cell trial results

Recruiting

A Multicentre, Non-Blinded Study Exploring Self-Administration of Chemotherapy in the Home Environment

NCT04268199

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: Arthur J.E. Child Comprehensive Cancer Centre Calgary, Alberta, Canada

Cross Cancer Institute Edmonton, Alberta, Canada

View Trial Details

Recruiting

Elotuzumab + Iberdomide + Dexamethasone Post Ide-Cel in RRMM

NCT06518551

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +18 more
Locations: Brigham and Women's Hospital Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Recruiting

Elranatamab Post Cilta-cel in Patients With Clinical High Risk Relapsed Myeloma

NCT06947083

Conditions: Myeloma, Neoplasms, Neoplasms by Histologic Type, +1 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

View Trial Details

Recruiting

Liquid Biopsy Evaluation and Repository Development at Princess Margaret

NCT03702309

Conditions: Adnexal Diseases, BRCA1 Mutation, BRCA2 Mutation, +85 more
Locations: Princess Margaret Cancer Centre Toronto, Ontario, Canada

View Trial Details

Recruiting

Subcutaneous Daratumumab Administration in the Thigh Vs Abdomen in Plasma Cell Disorders

NCT07075510

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Plasma Cell, +1 more
Locations: University of Maryland Greenebaum Comprehensive Cancer Center Baltimore, Maryland, United States

View Trial Details

Recruiting

Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer

NCT01137643

Conditions: Amyloidosis, Anemia, Anemia, Aplastic, +98 more
Locations: Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States

View Trial Details

Recruiting

Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Immunoglobulin Stopping or Extension (Stop Ig)

NCT07202091

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: Royal Adelaide Hospital Adelaide, South Australia, Australia

Austin Hospital Melbourne, Victoria, Australia

Northern Health Melbourne, Victoria, Australia

View Trial Details

Recruiting

Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Starting Immunoglobulin (Start Ig)

NCT07202078

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: Royal Adelaide Hospital Adelaide, South Australia, Australia

Austin Hospital Melbourne, Victoria, Australia

Northern Health Melbourne, Victoria, Australia

View Trial Details

Recruiting

Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Dosing Immunoglobulin (Dose Ig)

NCT07202065

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: Royal Adelaide Hospital Adelaide, South Australia, Australia

Austin Hospital Melbourne, Victoria, Australia

Northern Health Melbourne, Victoria, Australia

View Trial Details

Recruiting

Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Platform Trial (RATIONAL-PT)

NCT07202052

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: Royal Adelaide Hospital Adelaide, South Australia, Australia

Austin Hospital Melbourne, Victoria, Australia

Northern Health Melbourne, Victoria, Australia

View Trial Details